Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat

被引:53
|
作者
Mizusawa, H [1 ]
Hedlund, P
Brioni, JD
Sullivan, JP
Andersson, KE
机构
[1] Lund Univ, Dept Clin Pharmacol, S-22100 Lund, Sweden
[2] Abbott Labs, Div Pharmaceut Prod, Abbott Pk, IL 60064 USA
来源
JOURNAL OF UROLOGY | 2002年 / 167卷 / 05期
关键词
penis; rats; Sprague-Dawley; penile erection; guanylate cyclase;
D O I
10.1016/S0022-5347(05)65142-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Activation of soluble guanylate cyclase with a subsequent increase in intracellular levels of cyclic guanosine monophosphate is necessary for normal erection. In vascular tissue 3(5'-hydroxymethyl-2'-furyl-1-benzyI indazole (YC-1) (Abbott Laboratories, North Chicago, Illinois) has been shown to stimulate soluble guanylate cyclase independent of nitric oxide. We studied whether YC-1 modulates erectile responses in the rat. Materials and Methods: The effects of YC-1 given intracavernously or intraperitoneally on intracavernous pressure were investigated in rats. Functional effects of YC-1 on neuronal and endothelial nitric oxide relaxations were studied in 3 X 10(-6) M. 1-noradrenaline contracted preparations of rat isolated corpus cavernosum. Results: Intracavernous YC-1 (10 mumol. kg.(-1)) produced erectile responses with a mean intracavernous pressure plus or minus standard error of mean of 81 +/- 17 cm. water (p <0.001) and a mean duration of 7.1 +/- 3.3 minutes (p <0.001). YC-1 (10 mumol. kg.(-1)) given intraperitoneally also increased the amplitude and duration of erectile responses to cavernous nerve stimulation. Mean peak intracavernous pressure increased from 63 6 to 102 16 cm. water (p <0.05). Erections induced by a submaximal dose of 25 mu g. kg.(-1) apomorphine s.c. increased in number after 10 mu mol. kg.(-1) YC-1 intraperitoneally (p <0.05). In vitro nerve induced relaxant responses were enhanced by increasing concentrations of YC-1. Relaxations at 20 Hz. were increased from a mean of 9% +/- 5% to 52% +/- 5% at a YC-1 concentration of 10(-5) M. (p <0.001). At this concentration carbachol induced relaxations were enhanced from a mean of 19% +/- 3% to 40% +/- 9% (p <0.05). Conclusions: YC-1 can evoke erectile responses when given intracavernously and it enhances erections induced by cavernous nerve stimulation and apomorphine when given systemically. In vitro YC-1 enhances electrically evoked relaxations in rat corpus cavernosum. YC-1 represents an interesting pharmacological principle that may be useful for treating erectile dysfunction.
引用
收藏
页码:2276 / 2281
页数:6
相关论文
共 50 条
  • [1] Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1
    M Nakane
    G Hsieh
    L N Miller
    R Chang
    M A Terranova
    R B Moreland
    T Kolasa
    J D Brioni
    International Journal of Impotence Research, 2002, 14 : 121 - 127
  • [2] Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1
    Nakane, M
    Hsieh, G
    Miller, LN
    Chang, R
    Terranova, MA
    Moreland, RB
    Kolasa, T
    Brioni, JD
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (02) : 121 - 127
  • [3] YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium
    Cetin, A
    Kaya, T
    Demirkoprulu, N
    Karadas, B
    Duran, B
    Cetin, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (01) : 19 - 24
  • [4] Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1
    Chien, WL
    Liang, KC
    Teng, CM
    Kuo, SC
    Lee, FY
    Fu, WM
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (06) : 1679 - 1688
  • [5] YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice
    Teng, CM
    Wu, CC
    Ko, FN
    Lee, FY
    Kuo, SC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (2-3) : 161 - 166
  • [6] Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: Structural implication for the YC-1 binding site?
    Lamothe, M
    Chang, FJ
    Balashova, N
    Shirokov, R
    Beuve, A
    BIOCHEMISTRY, 2004, 43 (11) : 3039 - 3048
  • [7] YC-1 is not a pure agonist of the soluble guanylate cyclase
    Ruetten, H
    Keil, M
    Schoelkens, BA
    Martorana, PA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U50 - U50
  • [8] Synergistic activation of soluble guanylate cyclase by CO and YC-1: Effects of substrate
    Pal, B
    Li, ZQ
    Takenaka, S
    Tsuyama, S
    Kitagawa, T
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 96 (01) : 209 - 209
  • [9] Attenuated vasorelaxing activity to the nitric oxide-independent soluble guanylate cyclase activator YC-1 in eNOS deficient mouse aorta
    Li, DC
    Berkowitz, DE
    Mo, ZI
    Johns, RA
    ANESTHESIOLOGY, 2000, 93 (3A) : U168 - U168
  • [10] Structural and Functional Studies on the Nitric Oxide Receptor: YC-1 Binding to the PAS Domain of Soluble Guanylate Cyclase
    Purohit, Rahul
    Fritz, Bradley
    Brailey, Jacqueline
    Weichsel, Andrzej
    Roberts, Sue
    Montfort, William
    PROTEIN SCIENCE, 2012, 21 : 117 - 117